Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Open access
Wei, Jia, Pouwels, Koen B., Stoesser, Nicole, Matthews, Philippa C., Diamond, Ian, Studley, Ruth, Rourke, Emma, Cook, Duncan, Bell, John I., Newton, John N., Farrar, Jeremy, Howarth, Alison, Marsden, Brian D., Hoosdally, Sarah, Jones, E. Yvonne, Stuart, David I., Crook, Derrick W., Peto, Tim E. A., Walker, A. Sarah, Eyre, David W., the COVID-19 Infection Survey team, Thomas, Tina, Ayoubkhani, Daniel, Black, Russell, Felton, Antonio, Crees, Megan, Jones, Joel, Lloyd, Lina, Sutherland, Esther, Pritchard, Emma, Vihta, Karina-Doris, Doherty, George, Kavanagh, James, Chau, Kevin K., Hatch, Stephanie B., Ebner, Daniel, Ferreira, Lucas Martins, Christott, Thomas, Dejnirattisai, Wanwisa, Mongkolsapaya, Juthathip, Cameron, Sarah, Tamblin-Hopper, Phoebe, Wolna, Magda, Brown, Rachael, Cornall, Richard, Screaton, Gavin, Lythgoe, Katrina, Bonsall, David, Golubchik, Tanya, Fryer, Helen, Cox, Stuart, Paddon, Kevin, James, Tim, House, Thomas, Robotham, Julie, Birrell, Paul, Jordan, Helena, Sheppard, Tim, Athey, Graham, Moody, Dan, Curry, Leigh, Brereton, Pamela, Jarvis, Ian, Godsmark, Anna, Morris, George, Mallick, Bobby, Eeles, Phil, Hay, Jodie, VanSteenhouse, Harper, Lee, Jessica, White, Sean, Evans, Tim, Bloemberg, Lisa, Allison, Katie, Pandya, Anouska, Davis, Sophie, Conway, David I., MacLeod, Margaret, Cunningham, Chris · 2022 · Nature Medicine

Abstract

Antibody responses are an important part of immunity after Coronavirus Disease 2019 (COVID-19) vaccination. However, antibody trajectories and the associated duration of protection after a second vaccine dose remain unclear. In this study, we investigated anti-spike IgG antibody responses and correlates of protection after second doses of ChAdOx1 or BNT162b2 vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United Kingdom general population. In 222,493 individuals, we found significant boosting of anti-spike IgG by the second doses of both vaccines in all ages and using different dosing intervals, including the 3-week interval for BNT162b2. After second vaccination, BNT162b2 generated higher peak levels than ChAdOX1. Older individuals and males had lower peak levels with BNT162b2 but not ChAdOx1, whereas declines were similar across ages and sexes with ChAdOX1 or BNT162b2. Prior infection significantly increased antibody peak level and half-life with both vaccines. Anti-spike IgG levels were associated with protection from infection after vaccination and, to an even greater degree, after prior infection. At least 67% protection against infection was estimated to last for 2–3 months after two ChAdOx1 doses, for 5–8 months after two BNT162b2 doses in those without prior infection and for 1–2 years for those unvaccinated after natural infection. A third booster dose might be needed, prioritized to ChAdOx1 recipients and those more clinically vulnerable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-022-01721-6

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 236

Metadata

Authors
Wei, J., Pouwels, K. B., Stoesser, N., Matthews, P. C., Diamond, I., Studley, R., Rourke, E., Cook, D., Bell, J. I., Newton, J. N., Farrar, J., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Walker, A. S., Eyre, D. W., the COVID-19 Infection Survey team, Thomas, T., Ayoubkhani, D., Black, R., Felton, A., Crees, M., Jones, J., Lloyd, L., Sutherland, E., Pritchard, E., Vihta, K.-D., Doherty, G., Kavanagh, J., Chau, K. K., Hatch, S. B., Ebner, D., Ferreira, L. M., Christott, T., Dejnirattisai, W., Mongkolsapaya, J., Cameron, S., Tamblin-Hopper, P., Wolna, M., Brown, R., Cornall, R., Screaton, G., Lythgoe, K., Bonsall, D., Golubchik, T., Fryer, H., Cox, S., Paddon, K., James, T., House, T., Robotham, J., Birrell, P., Jordan, H., Sheppard, T., Athey, G., Moody, D., Curry, L., Brereton, P., Jarvis, I., Godsmark, A., Morris, G., Mallick, B., Eeles, P., Hay, J., VanSteenhouse, H., Lee, J., White, S., Evans, T., Bloemberg, L., Allison, K., Pandya, A., Davis, S., Conway, D. I., MacLeod, M., & Cunningham, C.
Venue
Nature Medicine
Published
2022-02-14
Volume
28
Issue
5
Pages
1072-1082
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4212781360
Cited by
236
References
18
FWCI
25.86
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. https://app.cochat.ai/papers/10.1038/s41591-022-01721-6
The paper
Wei, J., Pouwels, K. B., Stoesser, N., Matthews, P. C., Diamond, I., Studley, R., Rourke, E., Cook, D., Bell, J. I., Newton, J. N., Farrar, J., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Walker, A. S., . . . Cunningham, C. (2022). Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nature Medicine. https://doi.org/10.1038/s41591-022-01721-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.